If you want to distinguish your goods, services or both from those of another company, you may need a trademark or trade name. Find out what they are, what their registration procedure is and what it involves.
Information on the deadlines for filing applications for transformation of European Union trademarks into Spanish national trademarks. See more
If you have a new device, product or procedure that solves a technical problem or has a practical advantage, there are different ways to protect it in Spain and other countries. Find out how.
Does your innovation lie in the aesthetics, ornamentation or appearance of your product? Protect it through industrial design. Find out what rights registration confers and how to proceed.
Geographical indications protect the name of a product that has a specific geographical origin and owes its qualities, characteristics or reputation to its particular origin. Find out what they are, how the registration process works and what benefits they provide.
Patents published worldwide are a valuable source of scientific, technical and commercial information.
El Bono 3 del Fondo para PYMEs 2025, que cubre la elaboración de Informes Tecnológicos de Patentes (ITP) y Búsquedas Retrospectivas se cerrará el lunes 10 de febrero de 2025 al cierre de la jornada laboral. Próximamente se informará sobre su reapertura. Puede consultar más información aquí.
If you are an entrepreneur or a company and you want to boost and improve the profitability of your business by adequately protecting the intangible assets of your organisation, in this space you will find what you need.
420
results.
Updated on
15/07/2026 [07:52:00]
Results 25 to 50 of 420
Absstract of: WO2026147879A1
The present disclosure provides novel oligomers and polymerizable compositions comprising the same. Further provided herein are methods of producing polymers, polymer coatings, and devices. Also provided herein are methods of using polymer materials and polymer materials fabricated via additive manufacturing processes (e.g., via 3D printing), such as orthodontic appliances.
Absstract of: US20260191430A1
In certain implementations a computer-implemented method, computer program product and systems for performing gait analysis using lidar based three dimensional measurements is provided. Embodiments of the present invention can identify at least one object from received video information. Embodiments of the present invention can then estimate points on the object to depict two dimensional and three dimensional poses of the object based on a threshold number of frames depicting the object. Based on the estimated three dimensional poses, embodiments of the present invention can then generate measurements for biomechanical parameters that characterize movement of the object based on the estimated points on the object.
Absstract of: WO2026145785A1
A delayed-release oral drug dosage form, and a preparation method related to the oral drug dosage form, such as a three-dimensional printing method.
Absstract of: US20260191440A1
A system for detecting oximetry parameters of a user may include a reusable, wireless, and flexible near-infrared spectroscopy (NIRS) monitoring wearable system. The NIRS system may include a first component having a plurality of light sources configured to emit visible and infrared light at a plurality of wavelengths. The first component may have a first detector configured to detect a first plurality of signals from the plurality of light sources at a first source-detector distance of approximately 6 millimeters (mm) to 10 mm. The NIRS system may include a second component having a plurality of second detectors configured to detect a second plurality of signals from the plurality of light sources at multiple source-detector distances ranging from about 25 mm to about 45 mm. The NIRS system may include a memory, rechargeable battery, and processor configured to execute multi-depth tissue analysis.
Absstract of: US20260191458A1
0000 Methods and systems are provided for receiving labor-related data for one or more previous contractions of a patient, the labor-related data at least comprising data obtained with one of a tocodynamometer, an IUPC, and an EHG recording system, predicting labor-related data for a next contraction based on the labor-related data for one or more previous contractions, generating one or more visual indicators and one or more audio indicators based on output from a labor prediction model, the output from the labor prediction model being generated by entering the received labor-related data for the one or more previous contractions into the labor prediction model, the predicted labor-related data, and user input into the labor prediction model, and displaying the one or more visual indicators to a display device that is visible to the patient and outputting the one or more audio indicators to the patient.
Absstract of: US20260195728A1
This application describes systems and methods for locating, securing, accessing and utilizing a discrete enclosure or workspace. The discrete enclosure or workspace may be located in a public, private or semi-private setting and may comprise a combination of working platforms or surfaces, seats, desks and other apparatus, as well as computer hardware and software. Systems may comprise natural language processing, artificial intelligence, machine learning and other adaptive learning capabilities to enhance the use of the discrete workspace. The workspace may be dimensioned to be used for a wide variety of activities by one or more users.
Absstract of: US20260191454A1
Systems and methods to improve resource utilization in ambulatory patient monitoring are disclosed, including detecting a critical event using the physiologic information, transitioning the ambulatory medical device from a long-term ambulatory monitoring mode to a critical response mode, and controlling, in the critical response mode, transmission of an advertising packet and information about the detected critical event to a remote device in a continuous listening mode or transition of a communication circuit of the ambulatory medical device to a listening mode to receive an advertising packet of the remote device in a continuous advertising mode to transmit a connection response and information about the detected critical event to the remote device to improve resource utilization of the ambulatory patient monitoring.
Absstract of: US20260193576A1
0000 The invention relates to a cleaning solution for cleaning an object produced using a 3D printing method, to a method for cleaning an object produced using a 3D printing method by means of the cleaning solution according to the invention, and to the use of the cleaning solution according to the invention to clean an object produced using a 3D printing method. The cleaning solution according to the invention comprises a carbonate and water.
Absstract of: US20260192299A1
Improved sample container embodiments are provided for containing and supporting tissue samples during imaging. These sample containers support the samples to prevent distortion due to gravity and/or forces applied on the sample by elements of the container itself. Images generated for the samples thus more accurately reflects the geometry, composition, and orientation of the samples in the body prior to their removal. Such sample containers can include compliant cushions, which may be formed from sheets of material rather than solid volumes of foam or other materials. Such a reduction in cushion material proximate to the sample can result in improved sample imaging. The sample container can also be composed of fluid-impermeable materials to prevent absorption of fluid from the sample, reducing sample deformation and also reducing the imaging of the container material due to absorption of fluid from the sample.
Absstract of: US20260192078A1
0000 Provided herein is a system for treating chronic pain in a patient, the system including a user computing device including a display screen and a brain-computer interface (BCI) device communicatively coupled to the user computing device. The BCI device includes a processor communicatively coupled to an EEG headset and a vibrotactile device. The processor is configured to (i) prompt, through a display screen, the patient to carry out a plurality of cognitive tasks, the plurality of cognitive tasks selected to create theta activation brainwaves in the patient, (ii) monitor progress of the patient toward reaching a predetermined theta activation goal, (iii) display, through the display screen, a visual feedback via a cue, such as a goal bar, showing the progress of the patient in relation to the predetermined theta activation goal, and (iv) activate, in response to the patient reaching the predetermined theta activation goal, the vibrotactile device to generate multi-modal sensory feedback.
Absstract of: US20260191565A1
0000 A load-carrying rod for an implant system has a structure of individual interconnected solidified droplets so that the transitions from one droplet to another act as crack stoppers in the event of a crack.
Absstract of: AU2024395288A1
Certain aspects of the present disclosure relate to methods and systems for distinguishing between temporary compression of a sensor of a continuous analyte monitoring system and failure of the sensor, such as due to detachment of the sensor. In certain aspects, an apparatus includes an analyte sensor, a temperature sensor, a memory, and a processor communicatively coupled to the memory. The processor is configured to evaluate samples of an output of the analyte sensor and samples of an output of the temperature sensor with respect to a threshold condition. If the threshold condition is met, the processor is configured to generate a signal indicating failure of the analyte sensor.
Absstract of: WO2026146775A1
The present invention relates to a 3D printing resin composition for a transparent aligner, a method for preparing same, and a transparent aligner formed by 3D printing using same, the composition comprising 5-20 wt% UDMA (urethane dimethacrylate), 40-70 wt% BIS-GMA (bisphenol A-glycidyl methacrylate), 8-30 wt% BIS-EMA (ethoxylated bisphenol A dimethacrylate), 2-5 wt% TEGDMA (triethylene glycol dimethacrylate), 8-9 wt% modified PVA powder, 5-9 wt% of a filler, 0.72-3.7 wt% of a curing agent, and 0.1-1.0 wt% of an additive, wherein the transparent aligner can be modified to have a structure optimized for the oral cavities of individual users, and thus can maximize the aligning effect.
Absstract of: US20260196330A1
0000 Methods and systems for planning a trajectory for implanting electrical stimulation leads in a patient's brain are described. The methods and systems rank candidate trajectories based on their expected therapeutic efficacies, as well as other criteria. Optimized stimulation parameters are determined for each of the candidate trajectories and therapeutic efficacies using the optimized parameters are predicted.
Absstract of: US20260195933A1
0000 Described herein are devices for processing surgical video data associated with a surgery and methods of operating the same. An exemplary device includes a housing and a programmable circuit that is enclosed in the housing and configured to receive the surgical video data from a camera control unit. A processor is enclosed in the housing. The processor is communicatively coupled with the programmable circuit and is configured to execute a plurality of instructions for processing the video data stored on a memory. A galvanically isolated connector is exposed on the housing. The galvanically isolated connector is configured to be connected to a surgical device for contact with a patient during the surgery.
Absstract of: DE112023006984T5
Computerimplementiertes Verfahren zur Bereitstellung von Anzeigedaten für ein halbtransparentes Durchsichtanzeigegerät in einer medizinischen Umgebung, wobei das Verfahren die Schritte umfasst: Bereitstellen eines 2D- und/oder 3D-Modells eines ersten Objekts (Schritt S1); Empfangen von ersten Positionsdaten des ersten Objekts (Schritt S2); Empfangen von zweiten Positionsdaten eines zweiten Objekts (Schritt S3); Erfassen eines Freiraums basierend auf den zweiten Positionsdaten (Schritt S4); Bestimmen von Anzeigedaten zur Anzeige auf einem halbtransparenten Durchsichtanzeigegerät basierend auf dem 2D- und/oder 3D-Modell, dem erfassten Freiraum, den ersten Positionsdaten und den zweiten Positionsdaten (Schritt S5); und Bereitstellen der bestimmten Anzeigedaten zur Anzeige auf dem halbtransparenten Durchsichtanzeigegerät (Schritt S6).
Absstract of: DE112024003806T5
Es werden Systeme, Vorrichtungen und Verfahren zur Erstellung und Verwendung eines personalisierten, segment-spezifischen Endoskop-Rückzugsplans zur Steuerung eines endoskopischen Eingriffs offenbart. Ein Endoskopiesystem umfasst ein Endoskop und eine Steuerschaltung. Das Endoskop umfasst ein Bildgebungssystem zur Erfassung von Bildern oder Videodatenströmen einzelner anatomischer Segmente eines Patienten während eines endoskopischen Eingriffs. Die Steuerschaltung kann die Bilder oder Videodatenströme analysieren, um Bild- oder Videomerkmale für einzelne der unterschiedlichen Segmente der Anatomie zu generieren. Basierend auf den Bild- oder Videomerkmalen kann die Steuerschaltung einen Endoskop-Rückzugsplan generieren, der Ziel- oder empfohlene segment-spezifische Endoskop-Rückzugs-Parameterwerte für jedes der Segmente enthält. Der Endoskop-Rückzugsplan kann dem Benutzer oder einem Robotersystem bereitgestellt werden, um den manuellen oder robotergestützten Rückzug des Endoskops zu erleichtern.
Absstract of: US20260192048A1
0000 A continuous glucose monitor (CGM)-driven basal insulin titration system and method for patients with Type 2 Diabetes can be adapted to the needs and concerns of subjects just starting on basal insulin therapy. The method uses as inputs historical CGM data, basal insulin dose information, reports of hypoglycemia, and past recommendations and generates an adjusted insulin dose along with a report advising whether to continue the titration process, or to stop. The method can generate a new recommendation on a regular basis (e.g., each day) until it determines an adequate, consistent dose size.
Absstract of: US20260191456A1
Processes, algorithms and techniques are disclosed for detecting the presence of a source of at least one of heat, mass, momentum, energy, electrical field, and species in a system, such as, for identifying the presence of a heat source and its 3D location within a body part, and also to identify absence of a heat source within the body part. Multi-view thermal images are obtained of the body part and thermal and spatial information in different views are obtained. Iterative algorithms are developed to determine the presence of a heat source in the body part by employing the Physics-Informed Neural Network analyzer. Methods of generating a spatial-point-cloud and thermal-spatial-point-cloud are disclosed.
Absstract of: US20260191435A1
0000 Glucose level measurements of a user are obtained over time, such as from a wearable glucose monitoring device being worn by the user. These glucose level measurements can be produced substantially continuously, such that the device may be configured to produce the glucose level measurements at regular or irregular intervals of time, responsive to establishing a communicative coupling with a different device, and so forth. These glucose level measurements are analyzed to detect deviations from past glucose measurements, such as glucose measurements received earlier in the day or glucose measurements received at corresponding times of one or more preceding days. Indications of detected deviations are provided to the user or communicated elsewhere, such as to a healthcare professional.
Absstract of: US20260191629A1
0000 A consumable extrusion control system, a consumable extrusion control method and a consumable extrusion control device are provided. The consumable extrusion control system includes: a main body; a plurality consumable chambers coupled to the main body through respective pipelines; a plurality of first driving assemblies arranged on the respective pipelines for the consumable chambers, and configured to provide a driving force for consumables in the consumable chambers; and a control unit arranged at the main body, and configured to control and switch a corresponding first driving assembly to operate, to deliver the consumable from a corresponding one of the consumable chambers to the main body.
Absstract of: US20260191595A1
Systems and methods for designing and implementing patient-specific surgical procedures and/or medical devices are disclosed. In some embodiments, a method includes receiving intra-operative data during a surgical procedure to install a patient-specific implant in a patient. The system can compare the intra-operative data to a pre-operative plan to determine whether the implant is positioned and located according to the pre-operative plan.
Absstract of: US20260192047A1
0000 An infusion device includes a display and a pump configured for a predetermined volume per mechanical revolution (“VPMR”) under default environmental conditions. The infusion device receives infusion parameters that include (1) a requested flow rate of a fluid to be infused by the infusion device and, and (2) a head height and/or a patient height. The infusion device determines deviated environmental condition values as a function of (1) the received infusion parameters and (2) the default environmental conditions. The infusion device also determines a flow rate accuracy metric as a function of (1) the deviated environmental condition values and (2) an expected performance metric under the default environmental conditions. Responsive to determining the flow rate accuracy metric, the infusion device (a) displays, via the display, an indication of the flow rate accuracy metric; or (b) adjusts an operating speed of the pump based on the flow rate accuracy metric.
Absstract of: US20260196348A1
Provided herein are methods of training a model to detect cardiovascular disease in a subject from portable electrocardiogram (ECG) signal data and computer-implemented methods of detecting cardiovascular disease in a subject. The methods of training a model includes selecting an ECG dataset corresponding to a cardiovascular disease, the ECG dataset including multiple distinct ECGs, forming a training dataset from the ECG dataset, training the nodes of a deep neural network on the training dataset, and including random gaussian noise with each ECG of the ECG dataset during the training of the nodes. The computer-implemented methods of detecting cardiovascular disease in a subject include applying a deep neural network to ECG data for a subject, the deep neural network being trained according to the training methods disclosed herein.
Nº publicación: US20260196324A1 09/07/2026
Applicant:
BLUESIGHT INC [US]
Bluesight, Inc.
Absstract of: US20260196324A1
Methods and systems relate to providing varying levels of detail about a pharmacy item to a patient information system based on the capabilities of the patient information system. An intercept device can receive an identifier associated with a pharmacy item based on a scanner reading a computer-readable code. The intercept device can recognize or determine the storage capabilities or limitations of the patient information system, for example by determining various medication data fields that the patient information system uses to store pharmacy item information. The intercept device can use the machine readable code to obtain pharmacy item information that is compatible with the patient information system based on those storage capabilities or limitations and can distribute that pharmacy item information to the patient information system.
BOPI
Electronic site
